John F Stelmach Deceased1715 Gobi Trl, Green Bay, WI 54313

John Stelmach Phones & Addresses

1715 Gobi Trl, Green Bay, WI 54313 (920) 498-0264

Westfield, NJ

Mentions for John F Stelmach

Career records & work history

Medicine Doctors

John P. Stelmach

Specialties:
Orthopaedic Surgery
Work:
Commonwealth Orthopedic AssociatesKeystone Commonwealth Orthopedic Associates
1235 Penn Ave, Reading, PA 19610
(610) 779-2663 (phone) (610) 779-3367 (fax)
Site
Commonwealth Orthopedic Associates
11 Fairlane Rd, Reading, PA 19606
(610) 779-2663 (phone) (610) 779-3367 (fax)
Site
Education:
Medical School
Temple University School of Medicine
Graduated: 1987
Procedures:
Arthrocentesis, Hip Replacement, Hip/Femur Fractures and Dislocations, Knee Arthroscopy, Knee Replacement, Lower Arm/Elbow/Wrist Fractures and Dislocations, Lower Leg/Ankle Fractures and Dislocations, Shoulder Surgery
Conditions:
Fractures, Dislocations, Derangement, and Sprains, Internal Derangement of Knee, Internal Derangement of Knee Cartilage, Intervertebral Disc Degeneration, Lateral Epicondylitis, Osteoarthritis, Osteomyelitis, Rotator Cuff Syndrome and Allied Disorders, Sciatica, Scoliosis or Kyphoscoliosis, Spinal Stenosis
Languages:
English
Description:
Dr. Stelmach graduated from the Temple University School of Medicine in 1987. He works in Reading, PA and 1 other location and specializes in Orthopaedic Surgery. Dr. Stelmach is affiliated with Surgical Institute Of Reading.

License Records

John Paul Stelmach

Licenses:
License #: MT018385T - Expired
Category: Medicine
Type: Graduate Medical Trainee

John Stelmach resumes & CV records

Resumes

John Stelmach Photo 29

John Stelmach

John Stelmach Photo 30

John Stelmach

Publications & IP owners

Us Patents

(Halo-Benzo Carbonyl)Heterocyclo Fused Phenyl P38 Kinase Inhibiting Agents

US Patent:
6809199, Oct 26, 2004
Filed:
Dec 17, 2001
Appl. No.:
10/023231
Inventors:
James B. Doherty - Montvale NJ
John E. Stelmach - Westfield NJ
Meng-Hsin Chen - Westfield NJ
Luping Liu - Lawrenceville NJ
Julianne A. Hunt - Scotch Plains NJ
Rowena D. Ruzck - Old Bridge NJ
Joung L. Goulet - Westfield NJ
David D. Wisnoski - Somerset NJ
Swaminathan Ravi Natarajan - Edison NJ
Kathleen M. Rupprecht - Cranford NJ
Jianming Bao - Scotch Plains NJ
Shouwu Miao - Edison NJ
Xingfang Hong - Westfield NJ
Peter J. Sinclair - Scotch Plains NJ
Florida Kallashi - Yonkers NY
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
C07D23972
US Classification:
544256, 546122
Abstract:
Compounds described by the chemical formula (I) or a pharmaceutically acceptable salt thereof: are inhibitors of p38 useful in the treatment of inflammatory diseases such as arthritis.

(Halo-Benzo Carbonyl)Heterobi Cyclic P38 Linase Inhibiting Agents

US Patent:
7314873, Jan 1, 2008
Filed:
Jun 6, 2003
Appl. No.:
10/517754
Inventors:
James B. Doherty - Montvale NJ, US
Swaminathan R. Natarajan - Scotch Plains NJ, US
John E. Stelmach - Westfield NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31/5377
A61K 31/491
A61K 31/519
C07D 413/14
C07D 471/14
C07D 487/14
C07D 213/26
C07D 213/30
US Classification:
5142345, 5142641, 51425214, 544279, 544117, 546303, 546334
Abstract:
Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof: (I) are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

US Patent:
7687534, Mar 30, 2010
Filed:
Oct 2, 2007
Appl. No.:
11/906374
Inventors:
John E. Stelmach - Westfield NJ, US
Emma R. Parmee - Scotch Plains NJ, US
James R. Tata - Westfield NJ, US
Keith G. Rosauer - Laurence Harbor NJ, US
Ronald M. Kim - Summit NJ, US
Amy R. Bittner - Scotch Plains NJ, US
Jiang Chang - Westfield NJ, US
Christopher Joseph Sinz - Cranford NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/404
C07D 209/14
US Classification:
514415, 548511
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

US Patent:
7968589, Jun 28, 2011
Filed:
Feb 9, 2010
Appl. No.:
12/702358
Inventors:
John E. Stelmach - Westfield NJ, US
Emma R. Parmee - Scotch Plains NJ, US
James R. Tata - Westfield NJ, US
Keith G. Rosauer - Laurence Harbor NJ, US
Ronald M. Kim - Summit NJ, US
Amy R. Bittner - Scotch Plains NJ, US
Jiang Chang - Westfield NJ, US
Christopher Joseph Sinz - Cranford NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/404
C07D 209/10
US Classification:
514415, 548511
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Substituted Aryl And Heteroaryl Derivatives, Compositions Containing Such Compounds And Methods Of Use

US Patent:
8318760, Nov 27, 2012
Filed:
Mar 17, 2006
Appl. No.:
11/886136
Inventors:
John E. Stelmach - Westfield NJ, US
Keith G. Rosauer - Laurence Harbor NJ, US
Emma R. Parmee - Scotch Plains NJ, US
James R. Tata - Westfield NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A01N 43/40
A01N 43/64
A01N 37/44
A61K 31/41
C07D 213/00
C07D 293/00
C07D 207/00
C07C 61/00
C07C 63/00
C07C 321/00
C07C 323/00
US Classification:
514277, 514359, 514381, 514563, 546 1, 548100, 548400, 562400, 562405, 562427
Abstract:
Substituted aryl and heteroaryl derivatives are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

US Patent:
8436015, May 7, 2013
Filed:
Sep 10, 2009
Appl. No.:
13/063820
Inventors:
Songnian Lin - Monroe NJ, US
Christian P. Stevenson - Hoboken NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Libo Xu - Bridgewater NJ, US
Xibin Liao - Edison NJ, US
Edward Metzger - Somerset NJ, US
Rui Liang - East Brunswick NJ, US
Fengqi Zhang - Edison NJ, US
John E. Stelmach - Westfield NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A01N 43/42
A61K 31/47
C07D 215/00
US Classification:
514312, 546155
Abstract:
Glucagon receptor antagonist compounds of formula I are disclosed:.

Glucagon Receptor Antagonist Compounds

US Patent:
8445538, May 21, 2013
Filed:
Dec 9, 2009
Appl. No.:
13/140260
Inventors:
Songnian Lin - Monroe NJ, US
Xibin Liao - Edison NJ, US
Roman Kats-Kagan - Brooklyn NY, US
John E. Stelmach - Westfield NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/165
C07C 237/22
US Classification:
514616, 564157
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Ophthalmic Compositions For Treating Ocular Hypertension

US Patent:
2005025, Nov 17, 2005
Filed:
Jun 11, 2003
Appl. No.:
10/511636
Inventors:
Meng Hsin Chen - Westfield NJ, US
Luping Liu - Palainsboro NJ, US
Peter Meinke - Plainfield NJ, US
Ravi Natarajan - Scotch Plains NJ, US
William Parsons - Belle Mead NJ, US
Min Shu - Green Brook NJ, US
John Stelmach - Westfield NJ, US
Harold Wood - Westfield NJ, US
Fengqi Zhang - Edison NJ, US
David Wisnoski - Lansdale PA, US
James Doherty - Montvale NJ, US
International Classification:
A61K031/5377
A61K031/4439
A61K031/427
C07D417/02
C07D413/02
C07D043/02
US Classification:
514233500, 514370000, 548181000, 514337000, 546270700, 544143000
Abstract:
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.